JP2024525609A5 - - Google Patents
Info
- Publication number
- JP2024525609A5 JP2024525609A5 JP2024500475A JP2024500475A JP2024525609A5 JP 2024525609 A5 JP2024525609 A5 JP 2024525609A5 JP 2024500475 A JP2024500475 A JP 2024500475A JP 2024500475 A JP2024500475 A JP 2024500475A JP 2024525609 A5 JP2024525609 A5 JP 2024525609A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- polynucleotide according
- polynucleotide
- trop
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163220283P | 2021-07-09 | 2021-07-09 | |
| US63/220,283 | 2021-07-09 | ||
| PCT/US2022/073566 WO2023283644A2 (en) | 2021-07-09 | 2022-07-08 | Chimeric antigen receptor to target trop-2-positive cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525609A JP2024525609A (ja) | 2024-07-12 |
| JP2024525609A5 true JP2024525609A5 (enExample) | 2025-07-07 |
Family
ID=84802126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500475A Pending JP2024525609A (ja) | 2021-07-09 | 2022-07-08 | Ｔｒｏｐ－２陽性癌を標的とするキメラ抗原受容体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240325444A1 (enExample) |
| EP (1) | EP4366747A4 (enExample) |
| JP (1) | JP2024525609A (enExample) |
| KR (1) | KR20240034220A (enExample) |
| CN (1) | CN117881407A (enExample) |
| AU (1) | AU2022306051A1 (enExample) |
| CA (1) | CA3224887A1 (enExample) |
| IL (1) | IL309497A (enExample) |
| MX (1) | MX2024000479A (enExample) |
| WO (1) | WO2023283644A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4419128A4 (en) * | 2021-10-20 | 2025-10-01 | Univ Texas | NK CELL ENGINEERING WITH CAR CONSTRUCTION WITH OPTIMAL SIGNALING |
| GB202318553D0 (en) * | 2023-12-05 | 2024-01-17 | Unikum Therapeutics Aps | Engineered plasmacytoid dendritic cells |
| WO2025194098A1 (en) * | 2024-03-14 | 2025-09-18 | Dana-Farber Cancer Institute, Inc. | Engineered immune cells expressing chimeric antigen receptors targeting trop2, and methods of using the same |
| CN119215188B (zh) * | 2024-04-12 | 2025-09-05 | 英百瑞(杭州)生物医药有限公司 | 抗Trop2抗体和抗5T4抗体-自然杀伤细胞偶联物及其用途 |
| CN118307680A (zh) * | 2024-04-28 | 2024-07-09 | 华南农业大学 | 一种抗氯霉素单克隆抗体及其基于磁珠的自动化化学发光酶免疫检测方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2478047C (en) * | 2002-03-01 | 2014-01-21 | Immunomedics, Inc. | Rs7 antibodies |
| EP3227340B1 (en) * | 2014-12-04 | 2020-06-17 | Mediterranea Theranostic S.R.L. | Humanized anti-trop-2 monoclonal antibodies and uses thereof |
| AU2016274989A1 (en) * | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| WO2020009868A1 (en) * | 2018-07-03 | 2020-01-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-slamf7 chimeric antigen receptors |
| CN112771166B (zh) * | 2018-08-31 | 2025-03-04 | 诺伊尔免疫生物科技株式会社 | 表达car的t细胞和car表达载体 |
| AU2019372673A1 (en) * | 2018-11-01 | 2021-05-27 | Gracell Biotechnologies (Shanghai) Co., Ltd. | Compositions and methods for T cell engineering |
| CN119301157A (zh) * | 2022-05-30 | 2025-01-10 | 地中海治疗有限责任公司 | 用于癌症治疗的抗活化的Trop-2的嵌合抗原受体构建体 |
-
2022
- 2022-07-08 WO PCT/US2022/073566 patent/WO2023283644A2/en not_active Ceased
- 2022-07-08 KR KR1020247004709A patent/KR20240034220A/ko active Pending
- 2022-07-08 CA CA3224887A patent/CA3224887A1/en active Pending
- 2022-07-08 US US18/574,539 patent/US20240325444A1/en active Pending
- 2022-07-08 EP EP22838607.4A patent/EP4366747A4/en active Pending
- 2022-07-08 IL IL309497A patent/IL309497A/en unknown
- 2022-07-08 CN CN202280059099.5A patent/CN117881407A/zh active Pending
- 2022-07-08 AU AU2022306051A patent/AU2022306051A1/en active Pending
- 2022-07-08 JP JP2024500475A patent/JP2024525609A/ja active Pending
- 2022-07-08 MX MX2024000479A patent/MX2024000479A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024525609A5 (enExample) | ||
| AU2022204601B2 (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| US11725053B2 (en) | Chimeric antigen receptors comprising a human transferrin epitope sequence | |
| CN111566124A (zh) | 制备表达嵌合抗原受体的细胞的方法 | |
| JP2020513839A5 (enExample) | ||
| JP2017524367A5 (enExample) | ||
| JP2023509766A5 (enExample) | ||
| JP2023501617A5 (enExample) | ||
| JP2022548902A5 (enExample) | ||
| AU2022234333B2 (en) | Improving immune cell function | |
| JP2024527879A5 (enExample) | ||
| JP2024504164A5 (enExample) | ||
| KR20210111244A (ko) | 태반-유래 동종이계 car-t 세포 및 이의 용도 | |
| WO2022040631A1 (en) | Methods for isolating cd8+ selected t cells | |
| WO2024193714A1 (zh) | 细胞免疫疗法的组合物和方法 | |
| HK40086170A (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| IL313388A (en) | Chimeric antigen receptor-modified cells for the treatment of CLDN6-expressing cancer | |
| HK40077730B (zh) | 核酸、包含其的工程免疫细胞及其制备方法和用途 | |
| HK1248273A1 (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| HK1248273B (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| TH1801006150A (th) | ไคเมอริค รีเซพเตอร์ และวิธีการใช้สิ่งนั้น |